3416400773

BIBLIOGRAPHIE

Grumont, R.J., Rourke, I.J. and Gerondakis, S. Rel-dependent induction of Al transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev 1999; 13: 400-411.

Gu, J., Nie, L., Wiederschain, D. and Yuan, Z.M. Identification of p53 seąuence elements that are required for MDM2-mediated nuclear export. Mol Celi Biol 2001; 21: 8533-8546.

Guillouf, C., Rosselli, F., Krishnaraju, K., Moustacchi, E., Hoffman, B. and Liebermann, D.A. p53 involvement in control of G2 exit of the celi cycle: role in DNA damage-induced apoptosis. Oncogene 1995; 10: 2263-2270.

Guttridge, D.C., Albanese, C., Reuther, J.Y., Pestell, R.G. and Baldwin, A.S., Jr. NF-kappaB Controls celi growth and differentiation through transcriptional regulation of cyclin Dl. Mol Celi Biol 1999; 19: 5785-5799.

Hainaut, P. and Hollstein, M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 2000; 77: 81-137.

Ham, J., Dostatni, N., Gauthier, J.M. and Yaniv, M. The papillomavirus E2 protein: a factor with many talents. Trends Blochem Sci 1991; 16: 440-444.

Hartwell, L.H. and Kastan, M.B. Celi cycle control and cancer. Science 1994; 266: 1821-1828.

Haupt, Y., Maya, R., Kazaz, A. and Oren, M. Mdm2 promotes the rapid degradation of p53. Naturę 1997; 387: 296-299.

Hawkins, D.S., Demers, G.W. and Galloway, D.A. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 1996; 56: 892-898.

He, Z., Henricksen, L.A., Wold, M.S. and Ingles, C.J. RPA involvement in the damage-recognition and incision steps of nucleotide excision repair. Naturę 1995; 374: 566-569.

Hermann, D.M., Kuroiwa, T., Hata, R., Gillardon, F., Ito, U. and Mieś, G. Expression of redox factor-1, p53-activated gene 608 and caspase-3 messenger RNAs following repeated unilateral common carotid artery occlusion in gerbils-relationship to delayed celi injury and secondary failure of energy State. Neuroscience 2001; 102: 779-787.

Hermeking, H., Lengauer, C., Połyak, K., He, T.C., Zhang, L., Thiagalingam, S., KinzKer, K.W. and VogeIstein, B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Celi 1997; 1: 3-11.

Hickman, E.S., Bates, S. and Vousden, K.H. Perturbation of the p53 response by human papillomavirus type 16 E7. J Virol 1997; 71: 3710-3718.

Hinz, ML, Krappmann, D., Eichten, A., Heder, A., Scheidereit, C. and Strauss, M. NF-kappaB function in growth control: regulation of cyclin Dl expression and GO/Gl-to-S-phase transition. Mol Celi Biol 1999; 19: 2690-2698.

Hollander, M.C., Sheikh, M.S., Bulavin, D.V., Lundgren, K., Augeri-Henmueller, L., Shehee, R., Molinaro, T.A., Kim, K.E., Tolosa, E., Ashwcll, J.D., Rosenberg, M.P., Zhan, Q., Fernandez-Salguero, P.M., Morgan, W.F., Deng, C.X. and Fornace, A.J., Jr. Genomie instability in Gadd45a-deficient mice. Not Genet 1999; 23: 176-184.

Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. p53 mutations in human cancers. Science 1991; 253: 49-53.

Holmes, M.M., Weaver, S.H., 2nd and Vermillion, S.T. A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus. Infect Dis Ohstet Gynecol 1999; 7: 186-189.

Hottiger, M.O., Felzien, L.K. and Nabel, G.J. Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300. KmhoJ 1998; 17: 3124 3134.

172